CMG PharmaceuticalCMG제약
058820 · KOSDAQ · ₩058820 · CMG제약
₩4,370▼ ₩150 (3.32%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 55.8% | 57.9% | 46.1% | 46.5% | 49.8% | 48.1% |
| Operating margin | −3.1% | −3.5% | 1.0% | 3.2% | 3.6% | 2.4% |
| Net margin | 2.6% | −9.6% | 2.7% | 6.9% | −0.5% | 4.6% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +10.0% | +6.2% | +5.5% | +14.2% | +18.3% | — |
| Operating income growth | +1.7% | −461.9% | −66.4% | +1.9% | +79.6% | — |
| Net income growth | +130.4% | −474.0% | −58.3% | +1,763.2% | −112.3% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 1.5% | −5.2% | 1.4% | 3.4% | −0.2% | 1.7% |
| Return on assets | 0.9% | −3.3% | 1.0% | 2.8% | −0.2% | 1.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 56.7% | 51.8% | 60.1% | 27.3% | 15.3% | 7.8% |
| Net debt to equity | 27.5% | 32.5% | 40.6% | 12.8% | 0.8% | −2.5% |
| Current ratio | 117.4% | 91.8% | 180.7% | 471.8% | 616.7% | 914.0% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: CMG Pharmaceutical / CMG제약 / 058820 / KRX:058820
Source: KRX statistical information